Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ameren (AEE) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Ameren (AEE) over the last 17 years, with Q3 2025 value amounting to $167.0 million.

  • Ameren's Change in Receivables rose 7040.82% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $264.0 million, marking a year-over-year increase of 18387.1%. This contributed to the annual value of $91.0 million for FY2024, which is 16319.44% up from last year.
  • Latest data reveals that Ameren reported Change in Receivables of $167.0 million as of Q3 2025, which was up 7040.82% from $121.0 million recorded in Q2 2025.
  • Over the past 5 years, Ameren's Change in Receivables peaked at $167.0 million during Q3 2025, and registered a low of -$138.0 million during Q4 2021.
  • Over the past 5 years, Ameren's median Change in Receivables value was $70.0 million (recorded in 2022), while the average stood at $36.5 million.
  • As far as peak fluctuations go, Ameren's Change in Receivables skyrocketed by 224000.0% in 2022, and later crashed by 52857.14% in 2023.
  • Quarter analysis of 5 years shows Ameren's Change in Receivables stood at -$138.0 million in 2021, then skyrocketed by 115.22% to $21.0 million in 2022, then crashed by 528.57% to -$90.0 million in 2023, then dropped by 2.22% to -$92.0 million in 2024, then surged by 281.52% to $167.0 million in 2025.
  • Its Change in Receivables was $167.0 million in Q3 2025, compared to $121.0 million in Q2 2025 and $68.0 million in Q1 2025.